Insights Webinars

Webinars

Past webinar replays

•  

  Closing the Gap: Strategies for Resolving Imaging Discrepancies in Oncology Drug Trials

  Imaging plays a critical role in assessing drug efficacy in clinical trials. However, variability in imaging interpretation can lead to discrepancies in the trial results, which can have significant implications.This webinar explores the challenges associated with site versus central image reading in oncology clinical trials, how they impact trial results, and their root for better drug efficacy evaluation.This webinar covers the following topics: This webinar is intended for clinical trial sponsors, imaging experts, scientists, and anyone involved in designing and conducting imaging clinical trials. Don’t miss this opportunity to learn more about site versus central read variability and how to […]

  Know more

  

•  

  Decentralized Clinical Trials: The patient-centric future of oncology R&D?

  Join Labcorp Drug Development and Median Technologies leaders in a stimulating conversation to learn how proven, modern, decentralized clinical trial (DCT) strategies will improve patient compliance and engagement, accelerate timelines, and decrease site burden.

  Know more

  

•  

  Overcoming the challenges in deploying new imaging biomarkers in clinical trials – Perspectives from patients, physicians and other stakeholders

  This webinar is jointly organized by Labcorp Drug Development and Median Technologies. New Imaging biomarkers have a strong potential to provide additional insight for clinical trials: better selection of patients, prediction of response to therapy, early assessments of drug effects and safety. However, implementing them in clinical trials often promote challenges. The aim of this webinar is to discuss these challenges from the perspective of patients, physicians and the different stakeholders involved in the oncology clinical trials. Want to know more? Register now!

  Know more

  

•  

  Effective collaboration between imaging CRO and investigator sites contributes to successful clinical trials

  Investigator sites have an instrumental role in clinical trials, with endless responsibilities such as recruiting patients, acquiring, and submitting medical images to imaging CROs. Imaging CROs such as Median Technologies, will collect and review medical images to assess drug safety and efficacy based on the imaging endpoints. Efficient communication and streamlined processes between investigator sites and imaging CROs are key success factors for clinical trials in oncology. Want to know more? Watch the replay now!

  Know more

  

•  

  Discuss the 4 main causes of variability in centralized oncology radiological assessments

  Inter-reader variability can create challenges in oncology trial results. During this 45-minute presentation, Median Technologies addresses the 4 main causes of variability occurring during RECIST1.1 assessment and describes control strategies using data analytics and medical investigations. Want to know more? Watch the video now!

  Know more

  

Subscribe to receive email updates on our latest news and events.

Security check. Please enter the text below.

I agree to receive information about Median Technologies’ webinars, offers and services.

Median Technologies collects and process the minimum relevant information to treat your query efficiently. To know more about how we store and process your personal data and about your rights, see our personal data protection policy.

Subscribe